The CYP2D6 gene encodes the cytochrome P450 2D6 enzyme, which plays an important role in the metabolism of many drugs. The gene variations may affect the enzyme activity and, therefore, the processing and metabolizing of these drugs in the body.
The unique CYP2D6 variants may result in various forms of enzyme activity, which may have clinical implications in the use of certain drugs. Depending on the specific gene variant, patients may be classified as the “poor metabolizers”, “fast metabolizers” or “intermediate metabolizers” of drugs.
It is important to note that not all drugs depend on the CYP2D6 activity. Some drugs may be metabolized by other enzymes or have alternative metabolic pathways in the body. In addition, not all CYP2D6 variations have the same clinical significance in relation to each drug. This means that it is important to consider a particular drug and its interaction with the CYP2D6 gene in the individual context of each patient.
CYP2D6 genetic testing can be a useful tool in determining the tolerance and dosage of certain drugs. Test results can help your doctor make more informed decisions about the drug selection and its dosage adjustments.
Please contact us to book an appointment:
+ 375 17 385 97 39 (landline); +375 33 380 50 40 (Viber, WhatsApp, Telegram)
We are waiting for you at the following address: 27 Akademicheskaya St., Room 119, Minsk
27 Akademicheskaya St.
220072 Minsk
Belarus
